Head & Neck Cancer

Researchers are using artificial intelligence to diagnose sarcopenia in patients with head and neck cancer.

Bill C. Potts, author and five-time cancer survivor, lends his experience and tips about cancer to others in his book, “Up for the Fight.”

Patients with head and neck cancer treated with dysphagia-optimized intensity-modulated radiotherapy had improved swallow function compared with those treated with standard intensity-modulated radiotherapy.

Patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy reported higher quality of life and were less likely to experience vomiting when receiving fosaprepitant every week as opposed to every three weeks.

Researchers found a difference in outcomes between head and neck cancers with high and low expression of NF-kB, which may one day lead to more personalized treatments for the disease.

We recently asked our audience of patients, survivors and caregivers about the ongoing cisplatin and carboplatin shortage. Here’s what they had to say.

Caregivers of patients with head and neck cancer tend to face severe stress and burden related to their jobs, and it’s essential to implement more work-life balance.

A randomized clinical trial, CHEERS, determined that the combination of stereotactic body radiotherapy (SBRT) and immune checkpoint inhibitors (ICIs) were ineffective as treatment for patients with advanced solid tumors.

From Stand Up to Cancer honoring survivors at a Minor League baseball game, to Maria Menounos showing her cancer scars on Instagram, here’s what’s happening in the oncology space this week.

Patients with advanced cancers who live in states that expanded Medicaid were more likely to receive early palliative care, although utilization remains low in the U.S.

Caregiver burden was prevalent among caregivers of patients with head and neck cancer, due to lack of patient employment and poor health-related quality of life.

A chemotherapy shortage is resulting in altered treatment plans for many patients with cancer. CURE® spoke with experts about what that means for patients — and what they can do about it.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

Being overweight might improve overall survival and progression-free survival for patients with head and neck cancer undergoing chemoradiotherapy, recent research showed.

From Shannen Doherty’s announcement that her breast cancer spread to her brain to a nonprofit being established in memory of the late YouTuber, Technoblade, here’s what’s happening in the oncology space this week.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.

A patient with head and neck cancer highlights the importance of a strong support system throughout the time he was recovering from surgery.

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.

I had what I thought was a canker sore that didn't heal. It ended up being cancer.

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates.

After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.